AU775301B2 - Method for increasing the yield of recombinant proteins in microbial fermentation processes - Google Patents
Method for increasing the yield of recombinant proteins in microbial fermentation processes Download PDFInfo
- Publication number
- AU775301B2 AU775301B2 AU77763/00A AU7776300A AU775301B2 AU 775301 B2 AU775301 B2 AU 775301B2 AU 77763/00 A AU77763/00 A AU 77763/00A AU 7776300 A AU7776300 A AU 7776300A AU 775301 B2 AU775301 B2 AU 775301B2
- Authority
- AU
- Australia
- Prior art keywords
- duration
- cycle
- phase
- culture
- minutes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
PATENT
00362-PCT METHOD FOR INCREASING THE YIELD OF RECOMBINANT PROTEINS IN MICROBIAL FERMENTATION PROCESSES Industrial-scale production of recombinant proteins in bacteria takes place in fermenters. An increase in yield compared to laboratory-scale experiments done with flask shakers is achieved by increasing cell mass per volume. The batch-fed technique can achieve a high cell density. This is based on the growth-limiting addition of a nutrient source, whereby the carbon/energy source is generally limited (e.g.
Riesenberg D. and Guthke, 1999, App. Microbiol. Biotechnol. 51, 422-430). For E. coli processes, this is normally glucose or glycerol. Alternatively, depending on the microorganism used and the process, however, other substrates are used, such as molasses, starch, peptone, lactose, methanol, and acetate. Highly concentrated feed solution can be added continuously, with the possibility to use various functions to define the addition of the substrate over a period of time, or linearly increasing and decreasing. Various functions are often combined within a single process.
Alternatively, the nutritional solution can be added in pulses or at time intervals, with consumption of the nutrient or reduction of the amount of nutrient beneath a given concentration serving as the signal for the next pulse Terasawa et al., 1990, EP 0 397 097 Al). The addition of the substrate solution can also be regulated using other parameters. Dissolved oxygen (DO-stat), pH (pH-stat), or the concentrations of carbon dioxide and oxygen in the exhaust determined on line Kerns et al., Acta Biotechnol. 8, 285-289) can be used as control data, leading to cyclic dosing of the nutrient solution. In so doing, the concentration of the substrate is varied between a limiting and a nonlimiting concentration. Chen et al. (1997, Biotechnol. Bioeng. 56, 23-31) have measured increased plasmid stability when highly concentrated medium is periodically added to the batch-fed culture. In these procedures, one cycle can last several minutes or hours, which adversely effects product formation.
Standard vectors for gene expression are the plasmids, which, in addition to the replication origin, normally contain the DNA sequence that encodes for the desired protein (product gene), as well as a selection marker that serves to guarantee the stable preservation of the plasmid during culture growth. The expression of the product gene is normally controlled via regulatory sequences, particularly regulable
II
promoters. Expression of the product gene is activated, for example, by chemical inductors (substrates, substrate analogues), changes in cultivation temperature or other culturing conditions (pH value, salt concentration, degree of substrate concentration).
In particular, induction can also occur by changing the limiting substrate, or by induction of the tac-promoter with lactose and switching from glucose feeding to lactose feeding (Neubauer et al., 1992, Appl. Microbiol. Biotechnol. 36, 739-744).
Genes that provide the host cell with resistance to an antibiotic serve as selection markers for stable preservation of the plasmids in the host cells. Then, in the culture for the production of a recombinant protein, the corresponding antibiotic is normally added to kill off or inhibit the growth of plasmid-free cells that do not carry the resistance gene. Commonly used resistance gene/antibiotic pairs are Plactamase/ampicillin, chloramphenicol-acetyltransferase chloramphenicol, tetracycline resistance (tet)-operon/tetracycline, and kanamycin resistance gene kanamycin.
Some of these resistance systems have the disadvantage that the antibiotic is deactivated by the resistance gene, as with ampicillin and chloramphenicol (e.g.
Kemp G.W. and Britz 1987 Biotechnol. Techniques 1, 157-162). The consequence of this deactivation is that there is no obstacle to multiplication of plasmid-free cells in the culture. In addition, the proteins that mediate resistance can be released into the medium in the preparatory culture, accelerating the breakdown of the antibiotic. In these cases, the proportion of plasmid-free cells in the total culture can be increased. Moreover, no antibiotics are used in a large number of industrial processes for cost reasons or due to the additional expense incident to the subsequent cleaning, in which the remaining traces of the antibiotic or its deactivated form must be removed. A certain proportion of plasmid-free cells appears in such processes, as well.
While plasmid-free cells often only have a small growth advantage in the growth phase, in many cases, after product formation has begun, reduction in the growth rate of plasmid-containing, producing cells occurs, thus causing the culture to be overgrown by the plasmid-free cell population. The accumulation of plasmid-free cells has the disadvantage of reducing the relative proportion of the product in the 2 10806-193PCT P:\OPERm-7763-0 dclams do- e8O504 total cell mass, and, depending on the decomposition and cleaning methods chosen, making these postfermentation steps more difficult.
When constructing the vector, it is possible to limit these adverse effects, e.g. through selection of the resistance gene, the use of alternative antibiotic-independent stabilization systems (Molin and Gerdes, W084/01172), or by using modified antibiotics that break down more slowly; but the problematic resistances are still used. Moreover, none of the alternative systems is infinitely stable; stability can only be maintained for a certain time span.
Work leading to the present invention has addressed the problem of suppressing the overgrowth of plasmid-free cells after induction of recombinant product synthesis in batch-fed fermentations, particularly in industrial applications, without negative effects for product fermentation.
According to the present invention, there is provided a method for increasing the yield of recombinant proteins in a microbial fermentation process, wherein the concentration of a carbon/energy source in a culture is oscillating reduced or increased in cycles having a defined duration, wherein the maximum duration of one cycle is four minutes and the duration of a single phase of the cycle is a maximum of two minutes.
o Thus, the present invention provides a method which includes increasing/decreasing the concentration of the carbon/energy source in a cyclically oscillating pattern. This may be achieved by changing the rate of addition of the feed solution that contains the carbon/energy source, e.g. by corresponding programming of the pump that doses the feed solution. This S 25 leads to sequential phases, in which the cells either have a limited amount of substrate available to them or none at all.
*fee oooo oOO 0
OO•OO*
P:\OPER~\m77763-00 cljims doc- I W504 Contrary to the view held heretofore that oscillations adversely affect product formation in recombinant processes, targeted oscillations, with maximum cycle duration of four minutes, and individual phases of the cycle lasting a maximum of two minutes, surprisingly, have a positive influence on product yield. Cycle durations of approximately one minute (30 sec feeding, 30 sec pause) are particularly favorable.
The advantage of this method, which is principally applicable to all recombinant growthlimited processes in which the formation of the recombinant product is induced under carbon limitation, is that it is not necessary to add any further substances to the fermentation medium, that it is independent of the expression system used, and that is has no adverse effects on product formation. This procedure is particularly suited for batch-fed processes, in which a sugar, such as a glucose, lactose, *o
S*
o ***3A arabinose, or galactose, or other organic carbon sources, such as methanol, glycerol, molasses, or starch as a limiting nutrient are added to the culture. The procedure is independent of the cultivation medium, and can be used for cultivation on mineral salt medium as well as complex media.
This method is not limited to Escherichia coli as host organism; rather, it can be used with all microorganisms, such as Bacillus subtilis, Saccharomyces cerevisiae, or Pichia pastoris, which are cultivated using carbon-limited batch feed. It is also independent of the induction system. However, it is particularly advantageous when using the tac-promoter.
The procedure is particularly advantageous when the expression of the gene product is strongly induced and growth of the producing cells is adversely influenced compared to a noninduced culture. In addition, this procedure is advantageous in processes in which the production phase is particularly long, e.g. in the periplasmatic expression of recombinant proteins or when the product formation phase is connected with a shift in temperature.
Mode of Operation Strain and Plasmids Escherichia coli K-12 RB791 IN (rmD-rmE)1,X-,lacIqLg; E. coli Stock Center, New Haven, USA) was used as the host. This strain was transformed with the plasmid pKK177glucC (Kopetzki et al., 1989a), in which the cc-glucosidase gene from Saccharomyces cerevisiae is under the control of the tac-promoter. The plasmid contains the p-lactamase gene as its selection marker. Additionally, a second system was used, in which the plasmid pUBS520 (Brinkmann et al., 1989), which contains the dnaY gene (Minor-tRNA argU, AGA/AGG), was transformed in addition to the plasmid pKK177glucC.
4 10806-193PCT
II
Cultivation Medium and Fermentation Conditions Glucose-ammonium-mineral salt medium (Teich et al., 1998, J. Biotechnol. 64, 197- 210) was used for all cultivations. The initial concentration of glucose was 5 g The feed solution contained 200 g glucose kg and all components of the cultivation medium in the corresponding concentrations (Exception: (NH 4 2
SO
4 2.0 g and ml 1 of the trace element solution (Holme et al., 1970), but no MgSO 4 This was added during cultivation at 10ml of a 1 M MgSO 4 solution with OD 5 00 Ampicillin (100 mg and kanamycin (10 mg were added both to the preparatory cultures and the fermentation medium. Polypropylene glycol 2000 (50 was used as an antifoam agent.
Shake cultures on fermentation mineral salt medium, grown at 37 0 C, were used as the fermentation inoculum. All fermentations were carried out in 6 1 Biostat ED Bioreactors with an initial volume of 4 L and a temperature of 35 0 C. The cultures were started as a batch culture. In this phase, the aeration rate and the stirring were regulated in a cascade mode in order to maintain a DOT of at least 20%. At the end of the batch phase, the DOT control was deactivated and the aeration rate and stirring speed were set at 2 vvm or 800 rpm. The pH value was regulated at 7.0 using a ammonia solution. At the end of the batch phase, at a cell density of app. 2 g DCW 1 (OD500oo=9), the feeding pump was started at a constant rate of 53.2 g h (2.6 g glucose The total amount of glucose added was the same in all cultivations, independent of the feed mode. Three different feeding strategies were tested: (A) continuous feeding (controlled cultivation), intermittent feeding with a cycle of 1 minute (30 seconds on, 30 seconds off), intermittent feeding with a cycle of 4 minutes (2 minutes on, 2 minutes off). The expression of the a-glucosidase gene was induced after adding 1 mM IPTG 3 h after feeding was started, and product formation was followed over a time span of app. 20 h after induction.
Analytical Methods Cell growth was followed by measuring the optical density at 500 nm (OD 00 oo). The microscopic cell count was further determined in a counting chamber (0.02 mm depth), and the dry cell weight (DCW) was determined (see Teich et al. 1998, J.
10806-193PCT Biotechnol. 64, 197-210). The number of colony forming units (cfu) was determined by outcropping diluted samples on nutrient agar plates that were incubated for at least 3 days. Plasmid stability was then determined by overstamping these plates on selective agar with the replica plating technique. The relationship between DCW, OD500oo, and cell count was characterized as follows: lg/l DCW corresponds to an ODsoo of 4.5±0.1 and a cell count of 1.8x10 9 The glucose concentration was determined using a commercial enzyme kit.
The a-glucosidase concentration was determined after separating total cell samples in SDS gel collection gel, 7% separation gel). Expression was carried out by scanning the product strip and quantification compared with a product standard placed in the gel in various concentrations.
Results E. coli RB791 pKK177glucC and E. coli RB791 pKK177glucC pUBS520 were cultivated in an agitation reactor using glucose-limited batch feed. After the first batch phase, constant feeding was started and, three hours after the start of feeding, the expression of the a-glucosidase gene was induced by adding 1 mM IPTG. After induction, there is an increase in the a-glucosidase concentration, whereby the specific concentration of the enzyme per cell reaches its maximum approximately 5 h after induction, and begins to reduce in longer cultivation (see Fig. Ic). The reduction of the specific concentration of a-glucosidase is due to the overgrowth of the culture with plasmid-free cells. These have an enormous growth advantage after induction, as the production of a-glucosidase adversely affects growth and also causes an inhibition of glucose uptake in the producing cells. This leads to accumulation of glucose in the culture medium. Cells present in the culture that do not contain the product gene are not influenced by the inductor IPTG, but rather continue to grow without limitation due to the high availability of glucose.
If the glucose solution is not added continuously, but rather in short-cycle pulses at intervals of about one minute (see Materials and Methods), the a-glucosidase will accumulate similarly to the constant feed after induction. However, overgrowth of the 6 10806-193PCT culture by the plasmid-free cell population can be prevented depending on pulse duration (see Fig. Id). This positive effect on the suppression of plasmid-free cells was not only obvious in the strongly expressing system shown in Fig. 1, but also in the weak expression of a-glucosidase in the E. coli RB791 pKKl77glucC system (Fig. 2, table Moreover, pulse feeding had a slight positive influence on the synthesis rate in both cases after induction, and, in the first case, also on the stability of the product, more than 90% of which was present in the form of inclusion bodies.
Definition of the cycle time is an important factor. In both examples shown, prolonging cycle time to 4 min causes a reduction in the amount of the product, and thus of the yield (see Fig. 1, 2 and Table While the overgrowth of the culture by plasmid-free cells was reduced in this case as well, the longer cycle time leads to reduced product synthesis, or to increased breakdown.
Table 1: Productivity and Overgrowth by Plasmid-Free Cells in Glucose-Limited Batch-fed Cultures of E. coli RB791 pKKl77glucC with and without PUBS520 Type of substrate added a-glucosidase yield Plasmid-free cells during batch-fed fermentation [mg/g biomass] of total population] 3 h post 20 h post 3 h post 20 h post induction induction induction induction RB791 pKKl77glucC pUBS520 Constant feeding 37 30 2 72 Cycle 1 min 38 24 1 16 Cycle 4 min 37 6 2.5 RB791 pKK177glucC Cycle 1 min 10 9 10 Cycle 4min 6 4.6 15 6.7 10806-193PCT P \OPERims\7763-00 claims doc. IIOSA04 The figures show: Fig. 1: Batch-fed fermentations with E. coli RB791 pKK177glucC pUBS520 with induction by 1 mM IPTG. Comparison of continuous addition of glucose substrate solution open symbols: without induction; filled symbols: with induction) with cyclic addition of the same solution cycle of 1 min; V cycle of 4 min). (a,d) cell mass (DCW), glucose concentration, product formation (mg oaglucosidase g cell dry weight). The data shown represent a characteristic fermentation of 2 experiments performed for continuous addition and 1 experiment each for cyclic addition. Starting time for the addition of substrate solution induction with IPTG took place 3 h after feeding start Fig. 2: Batch-fed fermentations with E. coli RB791 pKKl77glucC with induction by 1 mM IPTG. Comparison of continuous addition of the glucose substrate solution (ac; open symbol: without induction; filled symbol: with induction) with cyclic addition of the same solution cycle of 1 min; V: cycle of 4 min). cell mass (DCW), glucose concentration, product formation (mg c-glucosidase g cell dry weight). For further explanations, see Fig. 1.
Fig. 3: shows the pump bowl scheme in a fermentation with a cycle of 1 min. A small 20 section of the fermentation is shown, with the reaction of the dissolved oxygen (DOT, as well as pump switching (0 =off, 1 on, Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", and or variations such as "comprises" or "comprising", will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps.
The reference to any prior art in this specification is not, and should not be taken as, an acknowledgment or any form of suggestion that that prior art forms part of the common *g general knowledge in Australia.
as•
Claims (8)
1. A method for increasing the yield of recombinant proteins in a microbial fermentation process, wherein the concentration of a carbon/energy source in a culture is oscillating reduced or increased in cycles having a defined duration, wherein the maximum duration of one cycle is four minutes and the duration of a single phase of the cycle is a maximum of two minutes.
2. The method according to claim 1 wherein the duration of one cycle is four minutes and the duration of each phase is two minutes.
3. The method according to claim 1 wherein the duration of one cycle is one minute and the duration of each phase is 30 seconds.
4. The method according to claim 1, wherein the duration of one cycle is one minute and the duration of a phase of the cycle is a maximum of 75% of the total cycle time. The method according to any one of claims 1 to 4 wherein said microbe is Escherichia coli.
6. The method according to any one of claims 1 to 5, wherein the oscillations are generated by changing a dosage rate of the feed solution containing the carbon/energy source.
7. The method according to claim 6, wherein the dosage rate is controlled by cyclical activation and deactivation of the addition of the feed solution. oioo S8. The method according to claim 6 or 7, wherein the carbon/energy source is added to :the culture in such a manner as to cyclically vary the rate of addition of the feed oo.: solution only during the induction phase of the process. °o oo
9. The method according to any one of claims 1 to 8, wherein the carbon/energy source is selected from the group consisting of glucose, glycerol, lactose, galactose, methanol, acetate, molasses, and starch. The method according to any one of claims 1 to 9, further comprising the addition of an inductor to the culture to induce formation of the recombinant product, wherein the inductor is selected from the group consisting of, IPTG, indolyl acrylic acid, lactose, arabinose, galactose, and methanol.
11. The method according to any one of claims 1 to 10, further comprising a temperature shift at the time of the induction of the formation of the recombinant product. Dated this 18 th day of May 2004. Pharmacia AB By its Patent Attorneys Davies Collison Cave g* S*oo ooo o o •go *e O~ *ooo *go go o* ooo o
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19943919A DE19943919B4 (en) | 1999-09-14 | 1999-09-14 | Process for increasing the yield of recombinant proteins in microbial fermentation processes |
DE19943919 | 1999-09-14 | ||
PCT/EP2000/008984 WO2001020016A2 (en) | 1999-09-14 | 2000-09-13 | Method for increasing the yield of recombinant proteins in microbial fermentation processes |
Publications (2)
Publication Number | Publication Date |
---|---|
AU7776300A AU7776300A (en) | 2001-04-17 |
AU775301B2 true AU775301B2 (en) | 2004-07-29 |
Family
ID=7921925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU77763/00A Ceased AU775301B2 (en) | 1999-09-14 | 2000-09-13 | Method for increasing the yield of recombinant proteins in microbial fermentation processes |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1212450A2 (en) |
JP (1) | JP2003530823A (en) |
KR (1) | KR20020048934A (en) |
CN (1) | CN1175113C (en) |
AU (1) | AU775301B2 (en) |
CA (1) | CA2383831A1 (en) |
DE (1) | DE19943919B4 (en) |
HK (1) | HK1052029A1 (en) |
IL (1) | IL148575A0 (en) |
NZ (1) | NZ517547A (en) |
WO (1) | WO2001020016A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10011728B4 (en) * | 2000-03-10 | 2005-02-10 | Andreas Schmid | Method for increasing the performance of microbial systems |
CA2426100A1 (en) | 2000-11-03 | 2002-05-23 | Genentech, Inc. | Metabolic rate shifts in fermentations expressing recombinant proteins |
WO2002059233A2 (en) | 2000-11-17 | 2002-08-01 | Microbes, Inc. | Microbial-induced controllable cracking of normal and branched alkanes in oils |
DK1434853T3 (en) * | 2001-10-01 | 2006-01-16 | Novozymes As | Fermentation with cyclic pulse / pause supply |
US20110008831A1 (en) * | 2005-05-26 | 2011-01-13 | Cytos Biotechnology Ag | Scalable fermentation process |
FI20065762A0 (en) * | 2006-11-30 | 2006-11-30 | Oulun Yliopisto | Procedure for controlling growth in cell culture |
CN106222152A (en) * | 2016-08-09 | 2016-12-14 | 苏州开元民生科技股份有限公司 | A kind of fermentation process producing () gamma-lactams enzyme recombination bacillus coli |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0397097A1 (en) * | 1989-05-08 | 1990-11-14 | Research Association For Utilization Of Light Oil | Cultivation of transformed microorganisms |
-
1999
- 1999-09-14 DE DE19943919A patent/DE19943919B4/en not_active Expired - Fee Related
-
2000
- 2000-09-13 JP JP2001523787A patent/JP2003530823A/en not_active Withdrawn
- 2000-09-13 AU AU77763/00A patent/AU775301B2/en not_active Ceased
- 2000-09-13 CN CNB008128936A patent/CN1175113C/en not_active Expired - Fee Related
- 2000-09-13 KR KR1020027003256A patent/KR20020048934A/en not_active Application Discontinuation
- 2000-09-13 WO PCT/EP2000/008984 patent/WO2001020016A2/en not_active Application Discontinuation
- 2000-09-13 CA CA002383831A patent/CA2383831A1/en not_active Abandoned
- 2000-09-13 IL IL14857500A patent/IL148575A0/en unknown
- 2000-09-13 EP EP00967674A patent/EP1212450A2/en not_active Withdrawn
- 2000-09-13 NZ NZ517547A patent/NZ517547A/en unknown
-
2003
- 2003-06-16 HK HK03104274A patent/HK1052029A1/en not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0397097A1 (en) * | 1989-05-08 | 1990-11-14 | Research Association For Utilization Of Light Oil | Cultivation of transformed microorganisms |
Non-Patent Citations (1)
Title |
---|
KERNS ET AL, ACTA BIOTECHNOLOGICA VOL 8, NO.3(1998) P.285-89 * |
Also Published As
Publication number | Publication date |
---|---|
NZ517547A (en) | 2004-03-26 |
CN1391614A (en) | 2003-01-15 |
IL148575A0 (en) | 2002-09-12 |
JP2003530823A (en) | 2003-10-21 |
CA2383831A1 (en) | 2001-03-22 |
WO2001020016A2 (en) | 2001-03-22 |
DE19943919B4 (en) | 2004-05-27 |
WO2001020016A3 (en) | 2001-05-17 |
EP1212450A2 (en) | 2002-06-12 |
AU7776300A (en) | 2001-04-17 |
CN1175113C (en) | 2004-11-10 |
DE19943919A1 (en) | 2001-03-22 |
KR20020048934A (en) | 2002-06-24 |
HK1052029A1 (en) | 2003-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Schweder et al. | Monitoring of genes that respond to process‐related stress in large‐scale bioprocesses | |
CN102732578B (en) | Produce the method for cadaverine | |
CN100582220C (en) | E.coli mutant containing mutant genes related with tryptophan biosynthesis and production method of tryptophan by using the same | |
JPH03501682A (en) | Escherichia coli BKIIM strain B-3996 as an L-threonine producer | |
CN101400799A (en) | Process for the production of beta-lysine | |
US6680181B2 (en) | Production of peptides | |
CN101688212B (en) | Corynebacterium glutamicum variety producing l-arginine and method for fabricating the same | |
AU775301B2 (en) | Method for increasing the yield of recombinant proteins in microbial fermentation processes | |
KR900007630B1 (en) | Cultivation with acetate concentration monitoring | |
RU2546239C1 (en) | RECOMBINANT STRAIN Escherichia coli, HAVING CONSTITUTIVE ASPARTASE ACTIVITY AND METHOD OF SYNTHESIS OF L-ASPARTIC ACID USING THIS STRAIN AS BIOCATALYST | |
US20110189733A1 (en) | Low cell density fermentation process for the production of heterologous recombinant proteins in microorganisms | |
US4745059A (en) | Process for the preparation of L-phenylalanine | |
AU4365899A (en) | Method for the isolation of ccc plasmid dna | |
KR20020060258A (en) | Production of peptides by fedbatch cultivation of a microorganism | |
KR101781294B1 (en) | High growth Escherichia coli using glycerol as carbon source | |
JPH0227980A (en) | Novel microorganism and preparation of d-biotin with the same microorganism | |
CA2362926A1 (en) | Method for producing l-sorbose | |
Ashby et al. | Stability of a plasmid F Trim in populations of a recombination-deficient strain of Escherichia coli in continuous culture | |
EP2287324A2 (en) | Fermentation processes with low concentrations of carbon- and nitrogen-containing nutrients | |
RU2620942C2 (en) | Plasmid-free recombinant escherichia coli strain, with constitutive aspartase activity and method for l-asparagin acid synthesis using this strain as biocatalyst | |
RU2209250C2 (en) | Method for microbiological processing waste in fractionating alcohol purification to yield protein biomass | |
RU2103349C1 (en) | Method of vegetable raw concentrating with microbial protein | |
CN116323960A (en) | Industrial fermentation process using partially harvested bacillus |